» Articles » PMID: 20409295

Human Macrophage Foam Cells Degrade Atherosclerotic Plaques Through Cathepsin K Mediated Processes

Overview
Publisher Biomed Central
Date 2010 Apr 23
PMID 20409295
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Proteolytic degradation of Type I Collagen by proteases may play an important role in remodeling of atherosclerotic plaques, contributing to increased risk of plaque rupture.The aim of the current study was to investigate whether human macrophage foam cells degrade the extracellular matrix (ECM) of atherosclerotic plaques by cathepsin K mediated processes.

Methods: We 1) cultured human macrophages on ECM and measured cathepsin K generated fragments of type I collagen (C-terminal fragments of Type I collagen (CTX-I) 2) investigated the presence of CTX-I in human coronary arteries and 3) finally investigated the clinical potential by measuring circulating CTX-I in women with and without radiographic evidence of aortic calcified atherosclerosis.

Results: Immune-histochemistry of early and advanced lesions of coronary arteries demonstrated co-localization of Cathepsin-K and CTX-I in areas of intimal hyperplasia and in shoulder regions of advanced plaques. Treatment of human monocytes with M-CSF or M-CSF+LDL generated macrophages and foam cells producing CTX-I when cultured on type I collagen enriched matrix. Circulating levels of CTX-I were not significantly different in women with aortic calcifications compared to those without.

Conclusions: Human macrophage foam cells degrade the atherosclerotic plaques though cathepsin K mediated processes, resulting in increase in levels of CTX-I. Serum CTX-I was not elevated in women with aortic calcification, likely due to the contribution of CTX-I from osteoclastic bone resorption which involves Cathepsin-K. The human macrophage model system may be used to identify important pathway leading to excessive proteolytic plaque remodeling and plaque rupture.

Citing Articles

Association of bone turnover biomarkers with severe intracranial and extracranial artery stenosis in type 2 diabetes mellitus patients.

Si S, Yang W, Luo H, Ma Y, Zhao H, Liu J World J Diabetes. 2023; 14(5):594-605.

PMID: 37273245 PMC: 10236991. DOI: 10.4239/wjd.v14.i5.594.


Cathepsin K contributed to disturbed flow-induced atherosclerosis is dependent on integrin-actin cytoskeleton-NF-κB pathway.

Fang F, Feng T, Li J, Zhang H, Wang Q, Chen Y Genes Dis. 2023; 10(2):583-595.

PMID: 37223522 PMC: 10201601. DOI: 10.1016/j.gendis.2022.03.020.


The Association of Coronary Artery Calcium Score and Osteoporosis in Postmenopausal Women: A Cross-Sectional Study.

Asadi M, Razi F, Fahimfar N, Shirani S, Behzad G, Salari P J Bone Metab. 2022; 29(4):245-254.

PMID: 36529867 PMC: 9760776. DOI: 10.11005/jbm.2022.29.4.245.


Macrophage-Osteoclast Associations: Origin, Polarization, and Subgroups.

Sun Y, Li J, Xie X, Gu F, Sui Z, Zhang K Front Immunol. 2021; 12:778078.

PMID: 34925351 PMC: 8672114. DOI: 10.3389/fimmu.2021.778078.


Ultra-selective carbon nanotubes for photoacoustic imaging of inflamed atherosclerotic plaques.

Gifani M, Eddins D, Kosuge H, Zhang Y, Paluri S, Larson T Adv Funct Mater. 2021; 31(37).

PMID: 34733130 PMC: 8559995. DOI: 10.1002/adfm.202101005.


References
1.
Liu J, Sukhova G, Sun J, Xu W, Libby P, Shi G . Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol. 2004; 24(8):1359-66. DOI: 10.1161/01.ATV.0000134530.27208.41. View

2.
Leeming D, Alexandersen P, Karsdal M, Qvist P, Schaller S, Tanko L . An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice. Eur J Clin Pharmacol. 2006; 62(10):781-92. DOI: 10.1007/s00228-006-0174-3. View

3.
Vaaraniemi J, Halleen J, Kaarlonen K, Ylipahkala H, Alatalo S, Andersson G . Intracellular machinery for matrix degradation in bone-resorbing osteoclasts. J Bone Miner Res. 2004; 19(9):1432-40. DOI: 10.1359/JBMR.040603. View

4.
Schaller S, Henriksen K, Hoegh-Andersen P, Sondergaard B, Sumer E, Tanko L . In vitro, ex vivo, and in vivo methodological approaches for studying therapeutic targets of osteoporosis and degenerative joint diseases: how biomarkers can assist?. Assay Drug Dev Technol. 2005; 3(5):553-80. DOI: 10.1089/adt.2005.3.553. View

5.
Clarkson T, PRICHARD R, Morgan T, Petrick G, Klein K . Remodeling of coronary arteries in human and nonhuman primates. JAMA. 1994; 271(4):289-94. View